Cargando…
P1680: HEALTH-RELATED QUALITY OF LIFE IN TRANSPLANT-INELIGIBLE REAL-LIFE MULTIPLE MYELOMA PATIENTS TREATED WITH FIXED-DURATION BORTEZOMIB-MELPHALAN-PREDNISONE VS. CONTINUOUS LENALIDOMIDE-DEXAMETHASONE
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430276/ http://dx.doi.org/10.1097/01.HS9.0000973592.99386.9a |
| _version_ | 1785090923781160960 |
|---|---|
| author | D’agostino, Mattia Bringhen, Sara Giuliani, Nicola Antonioli, Elisabetta Zambello, Renato Cattel, Francesco Ria, Roberto Allegra, Alessandro Leonardi, Giovanna Belotti, Angelo Galieni, Piero Margiotta-Casaluci, Gloria Cantonetti, Maria Cotugno, Valentina Gamberi, Barbara Pane, Fabrizio Liberati, Anna Marina Tosi, Patrizia Cavalli, Maide Maria Mannina, Donato Benevolo, Giulia Mangiacavalli, Silvia Evangelista, Andrea Ciccone, Giovannino Boccadoro, Mario Bruno, Benedetto Larocca, Alessandra |
| author_facet | D’agostino, Mattia Bringhen, Sara Giuliani, Nicola Antonioli, Elisabetta Zambello, Renato Cattel, Francesco Ria, Roberto Allegra, Alessandro Leonardi, Giovanna Belotti, Angelo Galieni, Piero Margiotta-Casaluci, Gloria Cantonetti, Maria Cotugno, Valentina Gamberi, Barbara Pane, Fabrizio Liberati, Anna Marina Tosi, Patrizia Cavalli, Maide Maria Mannina, Donato Benevolo, Giulia Mangiacavalli, Silvia Evangelista, Andrea Ciccone, Giovannino Boccadoro, Mario Bruno, Benedetto Larocca, Alessandra |
| author_sort | D’agostino, Mattia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430276 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104302762023-08-17 P1680: HEALTH-RELATED QUALITY OF LIFE IN TRANSPLANT-INELIGIBLE REAL-LIFE MULTIPLE MYELOMA PATIENTS TREATED WITH FIXED-DURATION BORTEZOMIB-MELPHALAN-PREDNISONE VS. CONTINUOUS LENALIDOMIDE-DEXAMETHASONE D’agostino, Mattia Bringhen, Sara Giuliani, Nicola Antonioli, Elisabetta Zambello, Renato Cattel, Francesco Ria, Roberto Allegra, Alessandro Leonardi, Giovanna Belotti, Angelo Galieni, Piero Margiotta-Casaluci, Gloria Cantonetti, Maria Cotugno, Valentina Gamberi, Barbara Pane, Fabrizio Liberati, Anna Marina Tosi, Patrizia Cavalli, Maide Maria Mannina, Donato Benevolo, Giulia Mangiacavalli, Silvia Evangelista, Andrea Ciccone, Giovannino Boccadoro, Mario Bruno, Benedetto Larocca, Alessandra Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430276/ http://dx.doi.org/10.1097/01.HS9.0000973592.99386.9a Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters D’agostino, Mattia Bringhen, Sara Giuliani, Nicola Antonioli, Elisabetta Zambello, Renato Cattel, Francesco Ria, Roberto Allegra, Alessandro Leonardi, Giovanna Belotti, Angelo Galieni, Piero Margiotta-Casaluci, Gloria Cantonetti, Maria Cotugno, Valentina Gamberi, Barbara Pane, Fabrizio Liberati, Anna Marina Tosi, Patrizia Cavalli, Maide Maria Mannina, Donato Benevolo, Giulia Mangiacavalli, Silvia Evangelista, Andrea Ciccone, Giovannino Boccadoro, Mario Bruno, Benedetto Larocca, Alessandra P1680: HEALTH-RELATED QUALITY OF LIFE IN TRANSPLANT-INELIGIBLE REAL-LIFE MULTIPLE MYELOMA PATIENTS TREATED WITH FIXED-DURATION BORTEZOMIB-MELPHALAN-PREDNISONE VS. CONTINUOUS LENALIDOMIDE-DEXAMETHASONE |
| title | P1680: HEALTH-RELATED QUALITY OF LIFE IN TRANSPLANT-INELIGIBLE REAL-LIFE MULTIPLE MYELOMA PATIENTS TREATED WITH FIXED-DURATION BORTEZOMIB-MELPHALAN-PREDNISONE VS. CONTINUOUS LENALIDOMIDE-DEXAMETHASONE |
| title_full | P1680: HEALTH-RELATED QUALITY OF LIFE IN TRANSPLANT-INELIGIBLE REAL-LIFE MULTIPLE MYELOMA PATIENTS TREATED WITH FIXED-DURATION BORTEZOMIB-MELPHALAN-PREDNISONE VS. CONTINUOUS LENALIDOMIDE-DEXAMETHASONE |
| title_fullStr | P1680: HEALTH-RELATED QUALITY OF LIFE IN TRANSPLANT-INELIGIBLE REAL-LIFE MULTIPLE MYELOMA PATIENTS TREATED WITH FIXED-DURATION BORTEZOMIB-MELPHALAN-PREDNISONE VS. CONTINUOUS LENALIDOMIDE-DEXAMETHASONE |
| title_full_unstemmed | P1680: HEALTH-RELATED QUALITY OF LIFE IN TRANSPLANT-INELIGIBLE REAL-LIFE MULTIPLE MYELOMA PATIENTS TREATED WITH FIXED-DURATION BORTEZOMIB-MELPHALAN-PREDNISONE VS. CONTINUOUS LENALIDOMIDE-DEXAMETHASONE |
| title_short | P1680: HEALTH-RELATED QUALITY OF LIFE IN TRANSPLANT-INELIGIBLE REAL-LIFE MULTIPLE MYELOMA PATIENTS TREATED WITH FIXED-DURATION BORTEZOMIB-MELPHALAN-PREDNISONE VS. CONTINUOUS LENALIDOMIDE-DEXAMETHASONE |
| title_sort | p1680: health-related quality of life in transplant-ineligible real-life multiple myeloma patients treated with fixed-duration bortezomib-melphalan-prednisone vs. continuous lenalidomide-dexamethasone |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430276/ http://dx.doi.org/10.1097/01.HS9.0000973592.99386.9a |
| work_keys_str_mv | AT dagostinomattia p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT bringhensara p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT giulianinicola p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT antoniolielisabetta p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT zambellorenato p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT cattelfrancesco p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT riaroberto p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT allegraalessandro p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT leonardigiovanna p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT belottiangelo p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT galienipiero p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT margiottacasalucigloria p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT cantonettimaria p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT cotugnovalentina p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT gamberibarbara p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT panefabrizio p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT liberatiannamarina p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT tosipatrizia p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT cavallimaidemaria p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT manninadonato p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT benevologiulia p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT mangiacavallisilvia p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT evangelistaandrea p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT cicconegiovannino p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT boccadoromario p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT brunobenedetto p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone AT laroccaalessandra p1680healthrelatedqualityoflifeintransplantineligiblereallifemultiplemyelomapatientstreatedwithfixeddurationbortezomibmelphalanprednisonevscontinuouslenalidomidedexamethasone |